Literature DB >> 1655323

Two types of TNF receptors are expressed on human normal and malignant B lymphocytes.

B Heilig1, M Mapara, M Brockhaus, K Krauth, B Dörken.   

Abstract

We analyzed the expression of the 75- and 55-kDa tumor necrosis factor (TNF) receptors on the surface of human normal and malignant B cells. Freshly isolated tonsillar B cells do not express detectable amounts of receptors. After 24 hr of stimulation with anti-IgM and low-molecular-weight (l.m.w.) BCGF, B cells express the 75-kDa receptor but not the 55-kDa receptor, but after 48 hr of stimulation both types of receptors are expressed. Three of 10 patients with B-chronic lymphatic leukemia or hairy cell leukemia (HCL) had a small population of TNF receptor positive tumor cells; after in vitro stimulation of tumor cells in 10/10 patients various patterns of 75- and 55-kDa TNF receptor expression were found. MAb UTR-1, which binds the 75-kDa receptor, inhibits the l.m.w. BCGF-induced [3H]thymidine incorporation of cultured tonsillar B cells and HCL cells. This may provide evidence that in B cells the 75 kDa TNF receptor molecule is functionally active.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655323     DOI: 10.1016/s0090-1229(05)80029-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis.

Authors:  B Heilig; M Wermann; H Gallati; M Brockhaus; B Berke; O Egen; A Pezzutto; W Hunstein
Journal:  Clin Investig       Date:  1992-01

Review 2.  Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Sang-Cheol Bae; Young Ho Lee
Journal:  Rheumatol Int       Date:  2014-04-29       Impact factor: 2.631

3.  Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation.

Authors:  P Aukrust; N B Liabakk; F Müller; T Espevik; S S Frøland
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

4.  Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.

Authors:  D W Miles; D Aderka; H Engelmann; D Wallach; F R Balkwill
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.